Cartilax (20mg) — Research Compound
Cartilax is a peptide bioregulator researched for its role in supporting cartilage homeostasis and connective tissue integrity. It belongs to a class of synthetic bioregulators that influence structural tissue repair by interacting with cellular signaling pathways involved in cartilage maintenance and regeneration.
Findings from early-stage clinical trials have reported:
- Improvements in cartilage regeneration and structural integrity reported in experimental joint models.
- Enhanced collagen synthesis and reductions in inflammatory signaling markers observed in-vivo.
- Improved recovery rates from cartilage tissue damage noted across research cohorts.
- Observed modulation of gene expression associated with joint tissue repair reported in cellular studies.
Researchers study Cartilax to investigate targeted peptide regulation of cartilage repair mechanisms and the molecular processes that support joint recovery and structural longevity.
Available Formats:
This compound is available as a vial of lyophilised powder, or can be ordered in a disposable pen, a reusable pen, or a cartridge for an existing reusable pen system.
Used solely for in vitro experiments and cannot be:
- Used in clinical trials involving humans
- Administered to humans as part of an experiment or investigation
- Supplied to another party for human investigational use
| IDENTIFICATION | |
| Product Name | Cartilax 20 mg |
| Catalogue Number | RP-CARTILAX-01 |
| CAS Number | 87815447 |
| Molecular Weight (g/mol) | Not uniquely defined |
| Molecular Formula | Peptide bioregulator (not uniquely defined) |
| Peptide Sequence | Cartilage-specific regulatory peptide |
| PHYSICAL AND CHEMICAL PROPERTIES | |
| Active Ingredient | Cartilax |
| Appearance | White to off-white lyophilised powder |
| Melting Point | Not applicable (decomposes before melting) |
| ANALYTICAL AND QUALITY CONTROL | |
| Mass Spectrum | Conforms to specification |
| Structural Confirmation | Consistent with theoretical structure / sequence |
| RESEARCH USE AND SAFETY | |
| Caution | Handle using appropriate PPE and in compliance with relevant laboratory safety standards. |
| Intended Use | For laboratory research use only. Not for human or veterinary use. |
| Hazard Classification | Not classified as hazardous under GHS for research quantities |
| STORAGE, HANDLING AND STABILITY | |
| Storage Temperature, Opened | -20 °C, minimise freeze–thaw cycles |
| Storage Temperature, Unopened | -20 °C recommended for long-term storage |
| Shelf Life | 2 years unopened under recommended conditions |
| Reconstitution Stability | Stable for up to 28 days at 2–8 °C in aqueous solution under sterile conditions |
Certificate of Analysis – Cartalax (99% Purity Verified)
| COMPOUND IDENTIFICATION | |
| Product Name | Cartalax 20mg |
| Batch / Reference ID | CA201111 |
| Sample Form | White powder in glass vial |
| ANALYTICAL RESULTS | |
| Chemical Purity | 99% (Verified) |
| Measured Content | 21.33 mg (± 0.05 mg) |
| Test Method | HPLC (High-Performance Liquid Chromatography) |
| LABORATORY TESTING INFORMATION | |
| Analysis Period | 06 Feb 2026 – 10 Feb 2026 |
| Laboratory Order # | 100012230 |
| QUALITY ASSURANCE | |
| Quality Testing Standards | All River Peptides products undergo batch-level laboratory analysis to verify compound identity and confirm purity levels. Learn more on our Quality Testing & Purity Verification page. |
Related Products
